resveratrol has been researched along with Anemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Chen, X; Huang, M; Li, F; Li, P; Ma, Y; Wei, R | 1 |
Booth, TD; Crowell, JA; Cwik, MJ; Horn, TL; Kapetanovic, I; McCormick, DL; Morrissey, RL | 1 |
2 other study(ies) available for resveratrol and Anemia
Article | Year |
---|---|
Luteolin can ameliorate renal interstitial fibrosis-induced renal anaemia through the SIRT1/FOXO3 pathway.
Topics: Anemia; Animals; Fibrosis; Kidney Diseases; Luteolin; Mice; Molecular Docking Simulation; Resveratrol; Sirtuin 1 | 2022 |
Oncogenicity evaluation of resveratrol in p53(+/-) (p53 knockout) mice.
Topics: Administration, Oral; Anemia; Aniline Compounds; Animals; Anticarcinogenic Agents; Carcinogenicity Tests; Carcinogens; Chemoprevention; Cholesterol; Dose-Response Relationship, Drug; Female; Hydronephrosis; Kidney; Liver; Longevity; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Organ Size; Resveratrol; Stilbenes; Tumor Suppressor Protein p53; Urinary Bladder | 2007 |